Antibody Drug Conjugates Market Forecast 2024–2034 Oncology Innovation Trends

The antibody-drug conjugates (ADC) market refers to the global industry that focuses on the development and commercialization of targeted cancer therapies that combine monoclonal antibodies with potent cytotoxic drugs. ADCs are engineered to deliver these powerful payloads directly to cancer cells while minimizing damage to healthy tissues, making them one of the most advanced forms of precision oncology. This market includes technologies focused on antibody engineering, linker chemistry, payload optimization and targeted drug delivery platforms to support a pipeline of therapies designed to improve safety and treatment outcomes in multiple cancer types.